REBECCA ASHY-HATCH: Open Payments
NPI 1740871706 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 9 payments from 8 companies in 2025. Trend: 2023 $681 · 2024 $704 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Sage Therapeutics, LLC | 1 | $100 |
| Edwards Lifesciences Corporation | 1 | $96 |
| Novo Nordisk Inc | 1 | $87 |
| KYOWA KIRIN, INC. | 1 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Amgen Inc. | 1 | $17 |
| ABIOMED | 1 | $15 |
Products named: TARPEYO, SAPIEN 3 Ultra RESILIA, Wegovy, LEQVIO, REPATHA.
Industry payments across LA — which companies pay providers there.
